We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.
Search results
From Proteopedia
You searched for Immunotherapeutic
There is no page with the exact title "Immunotherapeutic". The search results for "Immunotherapeutic" are displayed below. You can create a page titled Immunotherapeutic (by clicking on the red link).
For more information about searching Proteopedia, see Help.
To exclude pages titled with 4-character PDB codes, use the checkbox "only Human created pages" at the bottom of this page.
Showing below up to 20 results starting with #1.
View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)
Article title matches
- Category:Immunotherapeutic agent (54 bytes)
1: List of pages with the keyword Immunotherapeutic agent - Category:Immunotherapeutic (48 bytes)
1: List of pages with the keyword Immunotherapeutic
Page text matches
- 3w2d (4,019 bytes)
14: ...lizing antibodies have been shown to be effective immunotherapeutic agents against this toxin, but the structural bas... - 2wa0 (4,417 bytes)
23: ...active target for the development of targeted and immunotherapeutic cancer treatments. Some MAGE proteins are thought... - 2vwd (5,126 bytes)
24: ... for these viruses has enabled the development of immunotherapeutic reagents which prevent virus attachment and subse... - 8eoo (6,190 bytes)
14: ...cination or natural infection, has provided vital immunotherapeutic options for curbing the COVID-19 pandemic and has... - 2qhr (4,234 bytes)
23: ...or humanization and development of a postexposure immunotherapeutic. - Category:Immunotherapeutic agent (54 bytes)
1: List of pages with the keyword Immunotherapeutic agent - 2jrv (3,744 bytes)
13: Structural analysis of immunotherapeutic peptides for autoimmune Myasthenia gravis.,Jung H... - 2jrw (3,759 bytes)
13: Structural analysis of immunotherapeutic peptides for autoimmune Myasthenia gravis.,Jung H... - 3c3v (4,014 bytes)
24: ...city of food allergens and for the development of immunotherapeutic agents. Previously, we have reported the crystall... - 3csy (9,118 bytes)
24: ...chanism of EBOV GP-mediated fusion and for future immunotherapeutic development. - 3ft2 (14,035 bytes)
26: ... the choice of tumor peptides for stem cell-based immunotherapeutic application. - 3ft3 (5,847 bytes)
25: ... the choice of tumor peptides for stem cell-based immunotherapeutic application. - 3ft4 (5,829 bytes)
25: ... the choice of tumor peptides for stem cell-based immunotherapeutic application. - 3ifl (10,475 bytes)
25: ...dy. These findings provide a structural basis for immunotherapeutic strategies targeting Abeta species postulated to ... - 3ifn (10,476 bytes)
25: ...dy. These findings provide a structural basis for immunotherapeutic strategies targeting Abeta species postulated to ... - 3ifo (10,475 bytes)
25: ...dy. These findings provide a structural basis for immunotherapeutic strategies targeting Abeta species postulated to ... - 3ifp (10,476 bytes)
25: ...dy. These findings provide a structural basis for immunotherapeutic strategies targeting Abeta species postulated to ... - 3ujt (3,794 bytes)
12: ...se results inform the development of vaccines and immunotherapeutic/immunoprophylactic antibodies against Ft by sugge... - 3rtq (4,278 bytes)
14: ...NKT) cells by CD1d-presented agonists is a potent immunotherapeutic tool. alpha-Galactosylceramide (alpha-GalCer) is ... - 9dhy (5,275 bytes)
14: The Coronavirus Immunotherapeutic Consortium (CoVIC) conducted side-by-side compari...
View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)
You may also try
